SlideShare une entreprise Scribd logo
1  sur  49
Sepsis markers
Introduction
• Sepsis can occur suddenly and
deteriorate rapidly
• Timely diagnosis of sepsis is the key
of success
How to improve the outcome of
sepsis?
• Early diagnosis and
treatment
• Surviving Sepsis
Campaign .
Sepsis markers
• Diagnostic
– Useful for identifying or ruling out sepsis
– Identifying patients who may benefit from
specific therapies
• Assessing the response to therapy
• Prognostic
Ideal sepsis markers
• High sensitivity (increase pathologically in
the presence of disease)
• High specificity (does not increase in the
absence of disease)
• Related to the disease burden and extent
• Changes in accordance with the clinical
evolution
• Anticipates clinical changes before it
happens
Ideal sepsis markers
• Adds independent information
about the risk or prognosis
• Reproducible
• Easy and cheap
What do we have now?
• WCC
• Lactate
– Tissue perfusion variables
• Biomarkers
– C-reactive protein (CRP)
– Procalcitonin (PCT)
– Cytokines
– New markers
What do we have now?
• Large numbers of markers
– Cytokines
– Receptors biomarkers
– Coagulation biomarkers
– Biomarkers related to vascular endothelial
damage
– Markers related to organ dysfunction
– Acute phase protein biomarkers
– others
Sepsis markers
• Lactate
• C-reactive protein (CRP)
• Procalcitonin (PCT)
• Newer sepsis markers
Lactate production
Critical illness leading to increased tissue oxygen extraction
Oxygen delivery Oxygen consumption
Oxygen debt
Global tissue hypoxia
Anaerobic metabolism
Lactate production
Lactate
• Raised in severe sepsis and septic shock
– Hypoperfusion (secondary to anaerobic
metabolism)
– Cellular metabolic failure
– Decrease clearance by the liver
Prognostic and predict mortality
• It can be used as …
– Monitoring response of septic patients to resuscitation
– Stratification and prognosis
• Serial lactate level monitoring is recommended
– High lactate clearance:
• less required vasopressors therapy, greater improvements in
APACHE II scores and decreased mortality rates
Lactate clearance
• In patients with septic shock
– Survivors vs non-survivors
• Initial lactate level did not differ much
•Survivors had a significant
decrease in lactate levels and
less “lactate clearance time”
Lactate clearance
• Lactate clearance
– The percentage lactate decrease over the
initial 6 hr ED evaluation and treatment period
Lactate clearance
The higher the lactate
clearance, the lower the
mortality
CRP
• Acute phase protein
• Synthesized in liver
• IL-6 (and IL-1 and TNFα) stimulate
synthesis
• Binds bacterial polysaccharide/ chromatin
– Activates the classical complement pathway
– Increase the immune inflammatory response
• Esp. in bacteria infection (vs viral)
CRP
• Level of CRP begins within 4-6hrs after
stimulus
• Doubles every 8hrs
• Peaks at 36-50 hrs
• Half-life 19hrs
CRP
• A sensitive marker of inflammation and tissue damage
• Other conditions result in raised in CRP
– Rheumatological disease
• SLE
• Systemic sclerosis
• Dermatomyositis
• Sjogren’s disease
– Inflammatory bowel disease
– Haematological disease
• E.g. leukaemia
– Graft-versus-host disease
Procalcitonin
• A peptide precursor of calcitonin
• Produced by
– parafollicular cells of the thyroid
– neuroendocrine cells of the lung and the
intestine (extrathyroidal)
• It raises in a response to a
proinflammatory stimulus
– Esp of bacterial origin (mainly from the cells of
lung and the intestine)
PCT- characteristics
•Fast response (2-4hrs)
•Peak values 8-24hr
PCT- characteristics
• Short half-life (~24hrs) independent of
renal function
• Easy to measure in serum and plasma
(stable in vivo and in vitro)
• Plasma concentration ~ <0.05-1000ng/ml
• In systemic inflammation or in infection
– Persists as long as inflammatory process
continues
• Mechanical trauma
– Increase within 2-4hrs
– Peak in 1st
or 2nd
day then diminish
Procalcitonin (PCT)
• Reference values (except newborn)
– Significantly lower in leukopenic patients
< 0.05ng/ml Healthy individuals
< 0.5ng/ml Probability of sepsis
is low, local infection
possible
0.5-2ng/ml Grey zone, recheck
6-12hrs later
>2ng/ml Probability of sepsis
is high
Use of PCT
• Sepsis diagnosis
• Antibiotic guidance
• Patient prognosis
• Antibiotics were started/ stopped based on
a predefined cut-off ranges of PCT value
• Primary end point
– 28 and 60 days mortality
– No. of days without antibiotics
• PCT is also associated with other
conditions
– VAP
– Severe acute pancreatitis
– Acute exacerbation of COPD
Nonbacterial infection: Viruses, Fungi,
Parasites
• PCT tend to be low in viral infection
– However, in systemic viral infection, PCT value can
as high as 16 ng/ml
• A low serum PCT cannot be used to exclude
bacterial from viral infections but that a
combination of PCT, CRP, white blood cell
count, and clinical illness scoring might be more
useful
Nonbacterial infection: Viruses, Fungi,
Parasites
• In patients with fungal infections, results have
been variable
• Infection with the malaria parasite often leads to
very high levels of serum, as high as 662 ng/mL
Sepsis and PCT: The Pediatric Experience
• Variable in sensitivity and specificity
• Some authors recommended against the use of
PCT in routine diagnosis of bacterial sepsis in
neonates, because of more complicated PCT
measurement and its expense in comparison
with CRP.
Different features of CRP and PCT
• CRP levels may not further increase
during more severe stages of sepsis.
• PCT rises in proportion to the severity of
sepsis and reaches its highest levels in
septic shock.
Therefore, the diagnostic capacity of PCT isTherefore, the diagnostic capacity of PCT is
superior to that of CRP due to the closesuperior to that of CRP due to the close
correlation between PCT levels and thecorrelation between PCT levels and the
severity of sepsis and outcome.severity of sepsis and outcome.
Therefore, the diagnostic capacity of PCT isTherefore, the diagnostic capacity of PCT is
superior to that of CRP due to the closesuperior to that of CRP due to the close
correlation between PCT levels and thecorrelation between PCT levels and the
severity of sepsis and outcome.severity of sepsis and outcome.
Different features of CRP and PCT
• PCT reacted more quickly than CRP
• PCT concentrations had their maximum
levels prior to those of CRP
Allows anticipation of a
diagnosis of sepsis 24-48 hours
before the CRP level would
Allows anticipation of a
diagnosis of sepsis 24-48 hours
before the CRP level would
Different features of CRP and PCT
• CRP concentrations were high already during
the less severe stages of organ dysfunction and
systemic inflammation
– values were not much further increased during the
more severe stages of disease.
• PCT levels correlates with the stages of disease
(especially increased in patients with organ
dysfunction, severe sepsis or septic shock.)
CRP less useful in distinguishing evolution of
sepsis in severe sepsis and septic shock
CRP less useful in distinguishing evolution of
sepsis in severe sepsis and septic shock
Different features of CRP and PCT
• PCT concentrations more rapidly declined
as compared with CRP
CRP remained high even in the late
stage of disease
CRP remained high even in the late
stage of disease
Prognosis
• PCT levels were significantly associated with
– admission to a special care unit
– duration of intravenous antibiotic use
– total duration of antibiotic treatment
– length of hospital stay, whereas CRP was
related only to the latter two variables.
• These data suggest that PCT may be a valuable
addition to currently used markers of infection
for diagnosis of infection and prognosis in
patients with fever at the AED
New sepsis markers
• Soluble CD14 subtype
(Generic name- Presepsin)
• Heparin-Binding protein
• Others
Soluble CD14 subtype
Early diagnosis and prognosis
{ Presepsin }
Quick turn around time-
for emergency and intensive
care use
Quick turn around time-
for emergency and intensive
care use
Heparin-binding protein
• An early marker of circulatory failure in
sepsis
• Release from activated neutrophils
–A potent inducer of vascular leakage
–Resulted in extravasation of plasma and
WBC to the focus of infection
How about other markers?
• TNF-a
– The initiating factor in the activation of host
response and subsequent cytokine release
during infection
– Concentration increase 24 times after LPS
challenge during in vivo experimental
endotoxemia
• Short half-life of 17 min
– Short-term concentration in response to
bacterial challenge
However, the diagnostic utility of TNF is
insufficient for distinguishing infectious
inflammation
Why?
• Interleukin-6
– Increased concentrations correlating to infection
– Activation time: very short
– Half-life time ~ 1hr
– Sensitive early diagnosis of neonatal sepsis
– Adult values
• Sepsis 300-2700ng/L
• SIRS 100ng/L
– Usefulness in adult diagnosis has not well
established.
THANK YOU
SAMIR EL ANSARY

Contenu connexe

Tendances (20)

Acute phase reactants
Acute phase reactantsAcute phase reactants
Acute phase reactants
 
Sepsis update 2021
Sepsis update 2021Sepsis update 2021
Sepsis update 2021
 
Surviving Sepsis Campaign 2021 guidelines.pptx
Surviving Sepsis Campaign 2021 guidelines.pptxSurviving Sepsis Campaign 2021 guidelines.pptx
Surviving Sepsis Campaign 2021 guidelines.pptx
 
Sepsis 2017
Sepsis 2017Sepsis 2017
Sepsis 2017
 
Sepsis
SepsisSepsis
Sepsis
 
ACTEP2014: Sepsis marker in clinical use
ACTEP2014: Sepsis marker in clinical useACTEP2014: Sepsis marker in clinical use
ACTEP2014: Sepsis marker in clinical use
 
Sepsis
SepsisSepsis
Sepsis
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Sirs
SirsSirs
Sirs
 
Sepsis
SepsisSepsis
Sepsis
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
NT-ProBNP
NT-ProBNPNT-ProBNP
NT-ProBNP
 
A Case of Cryptococcal Meningitis
A Case of Cryptococcal MeningitisA Case of Cryptococcal Meningitis
A Case of Cryptococcal Meningitis
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
 
Septic shock management (1)
Septic shock management (1)Septic shock management (1)
Septic shock management (1)
 
Management of sepsis and septic shock
Management of sepsis and septic shockManagement of sepsis and septic shock
Management of sepsis and septic shock
 
Lpa and Genexpert/CBNAAT/Xpert MTB/Rif
Lpa and Genexpert/CBNAAT/Xpert MTB/RifLpa and Genexpert/CBNAAT/Xpert MTB/Rif
Lpa and Genexpert/CBNAAT/Xpert MTB/Rif
 
Opportunistic infections
Opportunistic infectionsOpportunistic infections
Opportunistic infections
 
Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML)Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML)
 
Spontaneous Bacterial Peritonitis (SBP)
Spontaneous Bacterial Peritonitis (SBP)Spontaneous Bacterial Peritonitis (SBP)
Spontaneous Bacterial Peritonitis (SBP)
 

En vedette

Significance of serum procalcitonin in sepsis
Significance   of    serum procalcitonin    in  sepsisSignificance   of    serum procalcitonin    in  sepsis
Significance of serum procalcitonin in sepsisLakshya K Solanki
 
Biomarkers in sepsis
Biomarkers in sepsisBiomarkers in sepsis
Biomarkers in sepsisNIICS
 
ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change taem
 
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...iosrjce
 
Platelet transfusion 2013
Platelet transfusion 2013Platelet transfusion 2013
Platelet transfusion 2013derosaMSKCC
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedKit GenSx
 
Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...
Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...
Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...Vall d'Hebron Institute of Research (VHIR)
 
Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundlehaley crise
 
CRP and inflammatory response (2)
CRP and inflammatory response (2)CRP and inflammatory response (2)
CRP and inflammatory response (2)Montse Juvany
 
The Sepsis Resuscitation And Management Bundles
The Sepsis Resuscitation And Management BundlesThe Sepsis Resuscitation And Management Bundles
The Sepsis Resuscitation And Management BundlesBilal Baig
 
CRP Presentation
CRP PresentationCRP Presentation
CRP Presentationkashif81
 
Types of Biomarkers
Types of Biomarkers Types of Biomarkers
Types of Biomarkers Mandeep Singh
 
Avv. Edoardo Tamagnone - Successioni Internazionali
Avv. Edoardo Tamagnone - Successioni InternazionaliAvv. Edoardo Tamagnone - Successioni Internazionali
Avv. Edoardo Tamagnone - Successioni InternazionaliEdoardo Tamagnone
 

En vedette (20)

Significance of serum procalcitonin in sepsis
Significance   of    serum procalcitonin    in  sepsisSignificance   of    serum procalcitonin    in  sepsis
Significance of serum procalcitonin in sepsis
 
Biomarkers in sepsis
Biomarkers in sepsisBiomarkers in sepsis
Biomarkers in sepsis
 
ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change
 
ARDS management
ARDS managementARDS management
ARDS management
 
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
 
Platelet transfusion 2013
Platelet transfusion 2013Platelet transfusion 2013
Platelet transfusion 2013
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revised
 
Lt118
Lt118Lt118
Lt118
 
Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...
Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...
Procalcitonin and MR-proAdrenomedullin as diagnostic and prognostic biomarker...
 
Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundle
 
CRP and inflammatory response (2)
CRP and inflammatory response (2)CRP and inflammatory response (2)
CRP and inflammatory response (2)
 
Procalcitonin
ProcalcitoninProcalcitonin
Procalcitonin
 
Haemodynamic monitoring
Haemodynamic monitoringHaemodynamic monitoring
Haemodynamic monitoring
 
The Sepsis Resuscitation And Management Bundles
The Sepsis Resuscitation And Management BundlesThe Sepsis Resuscitation And Management Bundles
The Sepsis Resuscitation And Management Bundles
 
Interleukins and interferon gamma
Interleukins and interferon gammaInterleukins and interferon gamma
Interleukins and interferon gamma
 
interleukins
 interleukins  interleukins
interleukins
 
CRP Presentation
CRP PresentationCRP Presentation
CRP Presentation
 
Types of Biomarkers
Types of Biomarkers Types of Biomarkers
Types of Biomarkers
 
Avv. Edoardo Tamagnone - Successioni Internazionali
Avv. Edoardo Tamagnone - Successioni InternazionaliAvv. Edoardo Tamagnone - Successioni Internazionali
Avv. Edoardo Tamagnone - Successioni Internazionali
 
Interleukins
InterleukinsInterleukins
Interleukins
 

Similaire à Early Diagnosis of Sepsis with Lactate, CRP, PCT & New Markers

Detection of sepsis and septic shock
Detection of sepsis and septic shockDetection of sepsis and septic shock
Detection of sepsis and septic shockAhmed Al-Abadlah
 
alyaa Management-of-Dengue-In-Primary-Care (1) (1).pptx
alyaa Management-of-Dengue-In-Primary-Care (1) (1).pptxalyaa Management-of-Dengue-In-Primary-Care (1) (1).pptx
alyaa Management-of-Dengue-In-Primary-Care (1) (1).pptxwithalya
 
Laboratory diagnosis of sepsis
Laboratory diagnosis of sepsisLaboratory diagnosis of sepsis
Laboratory diagnosis of sepsisNeha Sharma
 
12. Approach to Sepsis (Edited).ppt
12. Approach to Sepsis (Edited).ppt12. Approach to Sepsis (Edited).ppt
12. Approach to Sepsis (Edited).pptMisaleHaile
 
Laboratory Investigations In Rheumatology.pptx
Laboratory Investigations In Rheumatology.pptxLaboratory Investigations In Rheumatology.pptx
Laboratory Investigations In Rheumatology.pptxDrAmolRaut
 
Covid 19 management 6 months later
Covid 19 management 6 months laterCovid 19 management 6 months later
Covid 19 management 6 months laterWaheed Shouman
 
Management-of-Dengue-In-Primary-Care.pptx
Management-of-Dengue-In-Primary-Care.pptxManagement-of-Dengue-In-Primary-Care.pptx
Management-of-Dengue-In-Primary-Care.pptxwithalya
 
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesNoorulhaque Shaikh
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest updateRamadan Arafa
 
Peculiar features in sepsis.pptx
Peculiar features in sepsis.pptxPeculiar features in sepsis.pptx
Peculiar features in sepsis.pptxHermonhaile2
 
Community acquired pneumonia workshop
Community acquired pneumonia workshopCommunity acquired pneumonia workshop
Community acquired pneumonia workshopHiba Ashibany
 
C reactive protein
C  reactive proteinC  reactive protein
C reactive proteinManan Shah
 
Dengue in emergency department
Dengue in emergency departmentDengue in emergency department
Dengue in emergency departmentdayangrafidah
 
Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )
Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )
Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )Renuka Buche
 
Git j club ap16.
Git j club ap16.Git j club ap16.
Git j club ap16.Shaikhani.
 

Similaire à Early Diagnosis of Sepsis with Lactate, CRP, PCT & New Markers (20)

Detection of sepsis and septic shock
Detection of sepsis and septic shockDetection of sepsis and septic shock
Detection of sepsis and septic shock
 
alyaa Management-of-Dengue-In-Primary-Care (1) (1).pptx
alyaa Management-of-Dengue-In-Primary-Care (1) (1).pptxalyaa Management-of-Dengue-In-Primary-Care (1) (1).pptx
alyaa Management-of-Dengue-In-Primary-Care (1) (1).pptx
 
Laboratory diagnosis of sepsis
Laboratory diagnosis of sepsisLaboratory diagnosis of sepsis
Laboratory diagnosis of sepsis
 
12. Approach to Sepsis (Edited).ppt
12. Approach to Sepsis (Edited).ppt12. Approach to Sepsis (Edited).ppt
12. Approach to Sepsis (Edited).ppt
 
Laboratory Investigations In Rheumatology.pptx
Laboratory Investigations In Rheumatology.pptxLaboratory Investigations In Rheumatology.pptx
Laboratory Investigations In Rheumatology.pptx
 
Covid 19 management 6 months later
Covid 19 management 6 months laterCovid 19 management 6 months later
Covid 19 management 6 months later
 
Management-of-Dengue-In-Primary-Care.pptx
Management-of-Dengue-In-Primary-Care.pptxManagement-of-Dengue-In-Primary-Care.pptx
Management-of-Dengue-In-Primary-Care.pptx
 
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis Guidelines
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
 
Sepsis.pptx
Sepsis.pptxSepsis.pptx
Sepsis.pptx
 
Peculiar features in sepsis.pptx
Peculiar features in sepsis.pptxPeculiar features in sepsis.pptx
Peculiar features in sepsis.pptx
 
Dengue ppt Aiims
Dengue ppt AiimsDengue ppt Aiims
Dengue ppt Aiims
 
Community acquired pneumonia workshop
Community acquired pneumonia workshopCommunity acquired pneumonia workshop
Community acquired pneumonia workshop
 
C reactive protein
C  reactive proteinC  reactive protein
C reactive protein
 
Dengue
Dengue Dengue
Dengue
 
Ventriculitis.pptx
Ventriculitis.pptxVentriculitis.pptx
Ventriculitis.pptx
 
Dengue in emergency department
Dengue in emergency departmentDengue in emergency department
Dengue in emergency department
 
Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )
Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )
Community aquired pneumonia : Dr. Devawrat Buche MD (FNB )
 
biomarker in sepsis.pptx
biomarker in sepsis.pptxbiomarker in sepsis.pptx
biomarker in sepsis.pptx
 
Git j club ap16.
Git j club ap16.Git j club ap16.
Git j club ap16.
 

Plus de Dr. Mohamed Maged Kharabish

HTN guidelines For Elderly and whom with Renal impairement
HTN guidelines For Elderly and whom with Renal impairementHTN guidelines For Elderly and whom with Renal impairement
HTN guidelines For Elderly and whom with Renal impairementDr. Mohamed Maged Kharabish
 
NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIAS
NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIASNEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIAS
NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIASDr. Mohamed Maged Kharabish
 
Atrial arrhythmia in the critically ill patients
Atrial arrhythmia in the critically ill patientsAtrial arrhythmia in the critically ill patients
Atrial arrhythmia in the critically ill patientsDr. Mohamed Maged Kharabish
 

Plus de Dr. Mohamed Maged Kharabish (20)

DR.HASSAN ATRIAL FIBRILLATION 2023.ppt
DR.HASSAN ATRIAL FIBRILLATION 2023.pptDR.HASSAN ATRIAL FIBRILLATION 2023.ppt
DR.HASSAN ATRIAL FIBRILLATION 2023.ppt
 
Pressure Ulcer Management dr M Gaber .pptx
Pressure Ulcer Management dr M Gaber .pptxPressure Ulcer Management dr M Gaber .pptx
Pressure Ulcer Management dr M Gaber .pptx
 
Hyponatremia Mind Maps
Hyponatremia Mind MapsHyponatremia Mind Maps
Hyponatremia Mind Maps
 
Guidelines of blood transfusion
Guidelines of blood transfusionGuidelines of blood transfusion
Guidelines of blood transfusion
 
sepsis new guidelines 2017
sepsis new guidelines 2017sepsis new guidelines 2017
sepsis new guidelines 2017
 
Tg neuralgia
Tg neuralgiaTg neuralgia
Tg neuralgia
 
HTN guidelines For Elderly and whom with Renal impairement
HTN guidelines For Elderly and whom with Renal impairementHTN guidelines For Elderly and whom with Renal impairement
HTN guidelines For Elderly and whom with Renal impairement
 
Ards management
Ards managementArds management
Ards management
 
Cerebral salt wasting and siadh
Cerebral salt wasting and siadhCerebral salt wasting and siadh
Cerebral salt wasting and siadh
 
Beta blockers in brain injuries
Beta blockers in brain injuriesBeta blockers in brain injuries
Beta blockers in brain injuries
 
Hypertension
HypertensionHypertension
Hypertension
 
Cvp
CvpCvp
Cvp
 
Copd critically ill
Copd critically illCopd critically ill
Copd critically ill
 
Bedside invasive procedures in ccu
Bedside invasive procedures in ccuBedside invasive procedures in ccu
Bedside invasive procedures in ccu
 
My shock overview
My shock overviewMy shock overview
My shock overview
 
Emergency cadiac arrhythmias
Emergency cadiac arrhythmiasEmergency cadiac arrhythmias
Emergency cadiac arrhythmias
 
Echo.basics
Echo.basicsEcho.basics
Echo.basics
 
NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIAS
NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIASNEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIAS
NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIAS
 
Atrial arrhythmia in the critically ill patients
Atrial arrhythmia in the critically ill patientsAtrial arrhythmia in the critically ill patients
Atrial arrhythmia in the critically ill patients
 
SLE Pathophysiology and Management
SLE Pathophysiology and ManagementSLE Pathophysiology and Management
SLE Pathophysiology and Management
 

Dernier

Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 

Dernier (20)

Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 

Early Diagnosis of Sepsis with Lactate, CRP, PCT & New Markers

  • 2. Introduction • Sepsis can occur suddenly and deteriorate rapidly • Timely diagnosis of sepsis is the key of success
  • 3. How to improve the outcome of sepsis? • Early diagnosis and treatment • Surviving Sepsis Campaign .
  • 4. Sepsis markers • Diagnostic – Useful for identifying or ruling out sepsis – Identifying patients who may benefit from specific therapies • Assessing the response to therapy • Prognostic
  • 5.
  • 6. Ideal sepsis markers • High sensitivity (increase pathologically in the presence of disease) • High specificity (does not increase in the absence of disease) • Related to the disease burden and extent • Changes in accordance with the clinical evolution • Anticipates clinical changes before it happens
  • 7. Ideal sepsis markers • Adds independent information about the risk or prognosis • Reproducible • Easy and cheap
  • 8. What do we have now? • WCC • Lactate – Tissue perfusion variables • Biomarkers – C-reactive protein (CRP) – Procalcitonin (PCT) – Cytokines – New markers
  • 9. What do we have now? • Large numbers of markers – Cytokines – Receptors biomarkers – Coagulation biomarkers – Biomarkers related to vascular endothelial damage – Markers related to organ dysfunction – Acute phase protein biomarkers – others
  • 10. Sepsis markers • Lactate • C-reactive protein (CRP) • Procalcitonin (PCT) • Newer sepsis markers
  • 11. Lactate production Critical illness leading to increased tissue oxygen extraction Oxygen delivery Oxygen consumption Oxygen debt Global tissue hypoxia Anaerobic metabolism Lactate production
  • 12. Lactate • Raised in severe sepsis and septic shock – Hypoperfusion (secondary to anaerobic metabolism) – Cellular metabolic failure – Decrease clearance by the liver
  • 13.
  • 14. Prognostic and predict mortality • It can be used as … – Monitoring response of septic patients to resuscitation – Stratification and prognosis • Serial lactate level monitoring is recommended – High lactate clearance: • less required vasopressors therapy, greater improvements in APACHE II scores and decreased mortality rates
  • 15. Lactate clearance • In patients with septic shock – Survivors vs non-survivors • Initial lactate level did not differ much •Survivors had a significant decrease in lactate levels and less “lactate clearance time”
  • 16. Lactate clearance • Lactate clearance – The percentage lactate decrease over the initial 6 hr ED evaluation and treatment period
  • 17. Lactate clearance The higher the lactate clearance, the lower the mortality
  • 18. CRP • Acute phase protein • Synthesized in liver • IL-6 (and IL-1 and TNFα) stimulate synthesis • Binds bacterial polysaccharide/ chromatin – Activates the classical complement pathway – Increase the immune inflammatory response • Esp. in bacteria infection (vs viral)
  • 19. CRP • Level of CRP begins within 4-6hrs after stimulus • Doubles every 8hrs • Peaks at 36-50 hrs • Half-life 19hrs
  • 20. CRP • A sensitive marker of inflammation and tissue damage • Other conditions result in raised in CRP – Rheumatological disease • SLE • Systemic sclerosis • Dermatomyositis • Sjogren’s disease – Inflammatory bowel disease – Haematological disease • E.g. leukaemia – Graft-versus-host disease
  • 21. Procalcitonin • A peptide precursor of calcitonin • Produced by – parafollicular cells of the thyroid – neuroendocrine cells of the lung and the intestine (extrathyroidal) • It raises in a response to a proinflammatory stimulus – Esp of bacterial origin (mainly from the cells of lung and the intestine)
  • 22. PCT- characteristics •Fast response (2-4hrs) •Peak values 8-24hr
  • 23. PCT- characteristics • Short half-life (~24hrs) independent of renal function • Easy to measure in serum and plasma (stable in vivo and in vitro) • Plasma concentration ~ <0.05-1000ng/ml
  • 24. • In systemic inflammation or in infection – Persists as long as inflammatory process continues • Mechanical trauma – Increase within 2-4hrs – Peak in 1st or 2nd day then diminish
  • 25. Procalcitonin (PCT) • Reference values (except newborn) – Significantly lower in leukopenic patients < 0.05ng/ml Healthy individuals < 0.5ng/ml Probability of sepsis is low, local infection possible 0.5-2ng/ml Grey zone, recheck 6-12hrs later >2ng/ml Probability of sepsis is high
  • 26. Use of PCT • Sepsis diagnosis • Antibiotic guidance • Patient prognosis
  • 27. • Antibiotics were started/ stopped based on a predefined cut-off ranges of PCT value • Primary end point – 28 and 60 days mortality – No. of days without antibiotics
  • 28. • PCT is also associated with other conditions – VAP – Severe acute pancreatitis – Acute exacerbation of COPD
  • 29. Nonbacterial infection: Viruses, Fungi, Parasites • PCT tend to be low in viral infection – However, in systemic viral infection, PCT value can as high as 16 ng/ml • A low serum PCT cannot be used to exclude bacterial from viral infections but that a combination of PCT, CRP, white blood cell count, and clinical illness scoring might be more useful
  • 30. Nonbacterial infection: Viruses, Fungi, Parasites • In patients with fungal infections, results have been variable • Infection with the malaria parasite often leads to very high levels of serum, as high as 662 ng/mL
  • 31. Sepsis and PCT: The Pediatric Experience • Variable in sensitivity and specificity • Some authors recommended against the use of PCT in routine diagnosis of bacterial sepsis in neonates, because of more complicated PCT measurement and its expense in comparison with CRP.
  • 32. Different features of CRP and PCT • CRP levels may not further increase during more severe stages of sepsis. • PCT rises in proportion to the severity of sepsis and reaches its highest levels in septic shock. Therefore, the diagnostic capacity of PCT isTherefore, the diagnostic capacity of PCT is superior to that of CRP due to the closesuperior to that of CRP due to the close correlation between PCT levels and thecorrelation between PCT levels and the severity of sepsis and outcome.severity of sepsis and outcome. Therefore, the diagnostic capacity of PCT isTherefore, the diagnostic capacity of PCT is superior to that of CRP due to the closesuperior to that of CRP due to the close correlation between PCT levels and thecorrelation between PCT levels and the severity of sepsis and outcome.severity of sepsis and outcome.
  • 33. Different features of CRP and PCT • PCT reacted more quickly than CRP • PCT concentrations had their maximum levels prior to those of CRP Allows anticipation of a diagnosis of sepsis 24-48 hours before the CRP level would Allows anticipation of a diagnosis of sepsis 24-48 hours before the CRP level would
  • 34. Different features of CRP and PCT • CRP concentrations were high already during the less severe stages of organ dysfunction and systemic inflammation – values were not much further increased during the more severe stages of disease. • PCT levels correlates with the stages of disease (especially increased in patients with organ dysfunction, severe sepsis or septic shock.) CRP less useful in distinguishing evolution of sepsis in severe sepsis and septic shock CRP less useful in distinguishing evolution of sepsis in severe sepsis and septic shock
  • 35. Different features of CRP and PCT • PCT concentrations more rapidly declined as compared with CRP CRP remained high even in the late stage of disease CRP remained high even in the late stage of disease
  • 36.
  • 37. Prognosis • PCT levels were significantly associated with – admission to a special care unit – duration of intravenous antibiotic use – total duration of antibiotic treatment – length of hospital stay, whereas CRP was related only to the latter two variables. • These data suggest that PCT may be a valuable addition to currently used markers of infection for diagnosis of infection and prognosis in patients with fever at the AED
  • 38. New sepsis markers • Soluble CD14 subtype (Generic name- Presepsin) • Heparin-Binding protein • Others
  • 40.
  • 41.
  • 42. Early diagnosis and prognosis { Presepsin }
  • 43. Quick turn around time- for emergency and intensive care use Quick turn around time- for emergency and intensive care use
  • 44. Heparin-binding protein • An early marker of circulatory failure in sepsis • Release from activated neutrophils –A potent inducer of vascular leakage –Resulted in extravasation of plasma and WBC to the focus of infection
  • 45. How about other markers?
  • 46. • TNF-a – The initiating factor in the activation of host response and subsequent cytokine release during infection – Concentration increase 24 times after LPS challenge during in vivo experimental endotoxemia
  • 47. • Short half-life of 17 min – Short-term concentration in response to bacterial challenge However, the diagnostic utility of TNF is insufficient for distinguishing infectious inflammation Why?
  • 48. • Interleukin-6 – Increased concentrations correlating to infection – Activation time: very short – Half-life time ~ 1hr – Sensitive early diagnosis of neonatal sepsis – Adult values • Sepsis 300-2700ng/L • SIRS 100ng/L – Usefulness in adult diagnosis has not well established.